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Abstract
 DNA methylation reflects health-related environmentalBackground:
exposures and genetic risk, providing insights into aetiological mechanisms
and potentially predicting disease onset, progression and treatment response.
An increasingly recognised need for large-scale, longitudinally-profiled samples
collected world-wide has made the development of efficient and straightforward
sample collection and storage procedures a pressing issue. An alternative to
the low-temperature storage of EDTA tubes of venous blood samples, which
are frequently the source of the DNA used in such studies, is to collect and
store at room temperature blood samples using purpose built filter paper, such
as Whatman FTA® cards. Our goal was to determine whether DNA stored in
this manner can be used to generate DNA methylation profiles comparable to
those generated using blood samples frozen in EDTA tubes.
 DNA methylation profiles were obtained from matched EDTA tubeMethods:
and Whatman FTA® card whole-blood samples from 62 Generation Scotland:
Scottish Family Health Study participants using the Infinium
HumanMethylation450 BeadChip. Multiple quality control procedures were
implemented, the relationship between the two sample types assessed, and
epigenome-wide association studies (EWASs) performed for smoking status,
age and the interaction between these variables and sample storage method.
 Dried blood spot (DBS) DNA methylation profiles were of good qualityResults:
and DNA methylation profiles from matched DBS and EDTA tube samples
were highly correlated (mean   = 0.991) and could distinguish betweenr
participants. EWASs replicated established associations for smoking and age,
with no evidence for moderation by storage method.
 Our results support the use of Whatman FTA® cards forConclusions:
collecting and storing blood samples for DNA methylation profiling. This
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  Our results support the use of Whatman FTA® cards forConclusions:
collecting and storing blood samples for DNA methylation profiling. This
approach is likely to be particularly beneficial for large-scale studies and those
carried out in areas where freezer access is limited. Furthermore, our results
will inform consideration of the use of newborn heel prick DBSs for research
use.
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Introduction
Recent technological advances have facilitated the high- 
throughput genome-wide measurement of DNA methylation, 
yielding many studies reporting links between methylation 
and several conditions, diseases and phenotypes. The majority 
of studies have profiled DNA methylation in peripheral blood 
due to ease of sampling, which also renders it a useful tissue for 
identifying biomarkers. Blood samples for DNA methylation 
profiling are typically frozen prior to DNA extraction, with 
some samples being stored for years before use. As the sample 
numbers used for studies of DNA methylation, particularly 
epigenome-wide association studies (EWASs), continue to grow 
and the value of repeat sampling over time and exposures is 
recognised, so the logistical and financial issues surrounding 
whole blood sample collection and storage escalate. Moreover, 
population differences in DNA methylation1–4 highlight the 
need to profile DNA methylation around the world, including 
in low- and middle-income countries and rural settings, which 
might lack the required facilities for the low-temperature storage 
of EDTA blood collection tubes.
A potential alternative that would permit field collection and 
storage as well as postal collection is to collect finger or heel 
prick blood samples on filter paper5. As part of Generation 
Scotland: Scottish Family Health Study (GS:SFHS)6,7, Whatman 
FTA® cards were used to spot 100μl of the peripheral (venous) 
blood samples obtained at the baseline research clinic appoint-
ment, which took place between 2006 and 2011. These cards 
contain chemicals that lyse cell membranes and denature proteins, 
thus protecting DNA from degradation. Samples collected on 
these cards can be stored at room temperature for several years8 
prior to DNA extraction, thus avoiding the financial and logis-
tical issues associated with freezer storage. Whatman FTA® 
cards have been validated for genetic studies9–11; however, the 
effect of storing samples in this manner on the epigenome is 
less well-established. Previous studies provide support for the 
possibility of profiling DNA methylation in samples stored on 
Whatman FTA® cards8,12; however, these studies were limited 
by their focus on either a small number of individuals (n = 2)12 
or a single gene of interest8 and a relatively short time interval 
between sample collection and DNA extraction (maximum of 
approximately two years). Moreover, to the best of our knowl-
edge, no previous study has compared genome-wide DNA 
methylation profiles obtained from dried blood spots (DBSs) 
stored on Whatman FTA® cards with those from DNA from 
matched whole blood samples frozen in EDTA tubes (henceforth 
referred to as “EDTA samples”). 
The matched DBSs and EDTA samples obtained from GS:
SFHS6,7 have permitted us to carry out this comparison using 
samples from 62 participants. We show that it is technically 
feasible to measure DNA methylation from DBSs stored on 
Whatman FTA® cards, that the methylation profiles of DBS 
samples are highly correlated with those from EDTA samples 
from the same individuals, and that EWASs using DBS samples 
replicate well-established differentially methylated loci asso-
ciated with smoking and age. These findings indicate that this 
storage method represents a viable alternative to freezing blood 
samples for DNA methylation studies.
In addition to supporting the use of DBSs as a solution to the 
challenges posed by the need to collect and store large numbers 
of blood samples for DNA methylation studies in a wide-range 
of sociodemographic settings, our results also provide encour-
agement for the ability to profile DNA methylation in DBSs 
routinely collected on filter paper (commonly referred to as 
Guthrie cards) from new-born babies. The Guthrie cards are used 
clinically to screen for a prescribed set of metabolic and genetic 
disorders. These tests do not exhaust the sample and the remain-
ing material is typically stored, often indefinitely. The ability 
to profile DNA methylation from Guthrie cards would present 
a number of important opportunities13,14, including: addressing 
the issues of reverse causation and confounding, which plague 
EWASs; anchoring population studies of gene-environment 
interactions at the beginning of life; and permitting the develop-
ment of predictors of future disease onset, thus facilitating early 
intervention.
In Denmark, research access to Guthrie cards is possible through 
the Danish Newborn Screening Biobank15 and in 2017 it was 
estimated that almost 40% of the 2.1 million samples stored in 
this biobank had contributed to published research16. In Scotland, 
however, a moratorium on research access to Guthrie cards 
was imposed in 2009 and remains in place pending a public 
consultation17. An important step in determining whether medi-
cal researchers will be permitted access to this resource (over 
2.5 million cards collected since 1965, including 9,788 GS:SFHS 
participants with genome-wide genotype data and extensive 
phenotype data) will be assessments of the feasibility of obtain-
ing biologically meaningful and clinically valuable data from 
archived DBSs. Although the Whatman FTA® card is not iden-
tical to the card types used in the NHS Scotland new-born 
screening programme, some of the issues addressed in the present 
study, such as low DNA yield, a long period of storage, and the 
necessity of using a sample comprising heterogeneous cell types, 
are relevant to the potential use of Guthrie cards for research.
Methods
Cohort description
Genome-wide DNA methylation was profiled in whole blood 
samples from 62 GS:SFHS participants, chosen to have matched 
DNA samples from whole blood stored in EDTA tubes, DBSs 
stored on Whatman FTA® cards and complete phenotype data 
(on sex, age and smoking status). GS:SFHS has been described 
in detail elsewhere6,7; further information and information 
on research access can be found here. Studies arising from 
GS:SFHS can be found here. Briefly, GS:SFHS comprises 
~24,000 individuals who were aged 18 years or over at the time 
of recruitment. At the time of blood sample collection, partici-
pants were deeply phenotyped for a range of demographic, health, 
and social variables. A favourable ethical opinion for GS:SFHS 
was obtained from the NHS Tayside Committee on Medical 
Research Ethics, on behalf of the National Health Service 
(reference: 05/S1401/89). GS:SFHS has Research Tissue Bank 
Status (reference: 15/ES/0040).
Blood sample collection and DNA extraction
Each participant provided a blood sample (9ml), which was col-
lected in an EDTA tube for DNA extraction, when attending 
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the baseline GS:SFHS clinical appointment. This sample 
was stored at -20°C for between 33 and 497 days. At this point, 
100μl of the sample (approximately equivalent to two drops 
of blood) was blotted onto a Whatman FTA® classic card 
(GE Healthcare; cat. no. WB120205) and DNA was extracted 
from the remaining sample using the Nucleon BACC3 Genomic 
DNA Extraction Kit (GE Healthcare; cat. no. RPN8512)18, 
following the manufacturer’s instructions. The Whatman 
FTA® cards were stored at room temperature for between 5 and 
10 years until DNA extraction for this project. DNA was extracted 
from the entire blood spot using the QIAamp DNA Investiga-
tor Kit (Qiagen; cat. no. 56504), following the manufacturer’s 
instructions. The concentration of the DNA samples was meas-
ured using a Qubit 2.0 fluorometer and the Qubit dsDNA HS 
assay (Thermo Fisher; cat. no. Q32854). Sample storage, DNA 
extraction and DNA quantification took place at the Edinburgh 
Clinical Research Facility at the University of Edinburgh.
Genome-wide methylation profiling
Whole blood genomic DNA (EDTA samples: 500ng; DBS 
samples: 212–500ng) was treated with sodium bisulphite using 
the EZ-96 DNA Methylation Kit (Zymo Research; cat. no. 
D5004), following the manufacturer’s instructions. DNA meth-
ylation was profiled using the Infinium HumanMethylation450 
BeadChip (Illumina Inc.; cat. no. WG-314-1001), according to 
the manufacturer’s protocol. Paired EDTA and DBS samples 
from a given participant were profiled on separate slides and 
matched for row position.
Raw intensity (.idat) files were read into R19 v. 3.5.1 using minfi20 
v. 1.28.0 and quality control was carried out using shinyMethyl21 
v. 1.18.0 and functions within wateRmelon22 v. 1.26.0. ShinyMe-
thyl was used to create a “QC plot”, which plots the log median 
intensity of the unmethylated signal against the log median inten-
sity of the methylated signal for each array, and density plots of 
the beta-values separated by probe type (type 1 or 2) and colour 
channel for the type 1 probes. These plots were assessed for 
outlier samples by visual inspection. The performance of 
each of the 14 types of control probe on the array was assessed 
by inspecting plots created by shinyMethyl showing the raw 
signal intensities for each array. Outliers were assessed by visual 
inspection. ShinyMethyl’s sex prediction plot was used to 
assess whether a participant’s predicted sex based on the 
difference between the median copy number intensity for the 
Y chromosome and the median copy number intensity for the 
X chromosome matched their self-reported sex. Next, the pfilter 
function in wateRmelon was used to exclude poor-performing 
samples and probes. Samples with ≥ 1% sites with a detection 
p-value of > 0.05 were excluded. Probes were excluded from 
the dataset if: (i) ≥5% samples had a beadcount of < 3; or 
(ii) ≥ 0.5% samples had a detection p-value of > 0.05. Probes that 
had been predicted to cross-hybridise were removed using the 
rmSNPandCH function in the R package DMRcate23 v. 1.18.0, 
which removes cross-reactive probes identified by Chen et al.24. 
Probes on the X and Y chromosomes and those that target loci 
affected by a SNP at the CpG site or at the site of single base 
extension (in the case of Type 1 probes) were removed prior 
to carrying out EWASs.
The data from all samples were normalised together using the 
dasen method in wateRmelon. Dasen adjusts the background 
difference between Type I and Type II assays (by adding the 
offset between Type I and II probe intensities to Type I intensi-
ties) and then performs between-array quantile normalisation for 
the methylated and unmethylated signal intensities separately 
(Type I and Type II assays normalised separately).
Assessment of the relationship between detection p-value 
and DBS sample characteristics
A paired t-test was performed using R19 v. 3.5.1 to determine 
whether there was a difference in the total number of sites 
per sample with a poor detection p-value (detection p > 0.05) 
between the DBS and EDTA samples, with p ≤ 0.05 deemed to 
be significant. The relationships between the total number of sites 
for each sample with a detection p-value greater than 0.05 and 
(i) sample storage time and (ii) quantity of DNA hybridised 
to the array were assessed by linear modelling, with p ≤ 0.05 
deemed to be significant.
Estimation of whole blood cellular composition
Estimated cell counts for B-lymphocytes, granulocytes, mono-
cytes, natural killer cells, CD4+ T-lymphocytes and CD8+ 
T-lymphocytes were obtained using the estimateCellCounts func-
tion in minfi. This function implements Jaffe and Irizarry’s25 
modification of Houseman’s26 algorithm. Paired t-tests were 
performed to assess whether blood storage method (EDTA tube vs. 
Whatman FTA® card) affected cellular composition. Correction 
for multiple testing was implemented using the Benjamini-
Hochberg false discovery rate (FDR), with q-values of ≤ 0.05 
deemed to be significant.
Assessment of the correlation between methylation profiles 
obtained from EDTA tube and DBS paired samples and 
unsupervised hierarchical clustering
Following the method described by Hannon et al. (2015)27, a set 
of probes deemed to be variable in our sample was identified. 
The pair-wise correlation between all samples was assessed by 
calculating Pearson correlation coefficients. Unsupervised hier-
archical clustering plots were generated using the R package 
lumi28 v. 2.34.0 using the same set of variable probes as used for 
the correlation analysis.
Identification of differentially methylated positions 
associated with smoking or age and the interaction with 
storage method
EWASs were carried out (i) to identify loci where DNA meth-
ylation is associated with smoking or age in the EDTA or DBS 
samples and (ii) to establish whether these associations were 
moderated by storage method. EWASs for smoking and age were 
implemented in the R package limma29 v. 3.38.3 by fitting linear 
models in which DNA methylation (beta-value) was the outcome 
variable and age or smoking (a categorical variable with the 
following levels: current smoker, former smoker who gave up 
under 12 months ago, former smoker who gave up 12 months 
or longer ago, or never smoked) was the predictor of interest. 
When smoking status was the predictor of interest, the following 
covariates were included in the model: age, sex, slide ID, row 
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number and estimated proportions of B-lymphocytes, granu-
locytes, natural killer cells, CD4+ T-lymphocytes and CD8+ 
T-lymphocytes. The same covariates were included for the EWAS 
of age with the addition of “pack years”, a measure that indi-
cates an individual’s lifetime exposure to tobacco. Pack years 
were calculated by multiplying the years an individual had 
smoked for by the maximum number of packs of cigarettes they 
ever smoked per day (a pack = 20 cigarettes). A conversion was 
used for cigars (a cigar = four cigarettes) and rolling tobacco 
(a 25g pack = 50 cigarettes). EWASs to assess the interaction 
between smoking status or age and storage method (EDTA tube 
or Whatman FTA® card) were carried out using linear mixed 
effects models implemented in the R package nlme30 v. 3.1-137. 
The fixed effects were the same as for the main effects 
EWASs, with the addition of a variable representing storage 
method, and each participant was modelled with a random inter-
cept. The threshold for significance was defined as p ≤ 3.6 × 10-8, 
as recommended by Saffari et al. (2018)31.
Results
Extraction of DNA from DBSs stored on Whatman FTA® 
cards
The concentration of the DNA extracted from the DBSs ranged 
from 3.8 ng/μl to 145.8 ng/μl, with a mean yield of 18.0 ng/μl, 
in a total volume of 50 μl. The recommended minimum input 
for the Infinium HumanMethylation450 BeadChip, 500 ng 
DNA, was available for 43 of the 62 samples, with all but two 
samples having at least 250 ng DNA as input. The lowest array 
input was 212 ng DNA.
Quality control of DNA methylation arrays
Initial assessment of array performance using the R package 
shinyMethyl indicated that all arrays had performed well. Neither 
the QC plot (Figure 1) nor the density plots of M-values and 
beta-values (Figure 2) produced using shinyMethyl indicated 
any obvious outliers. Both plot types did, however, indicate 
a slight shift between the EDTA and DBS samples. From the 
QC plot it can be seen that there was a tendency for the DBS 
samples to have slightly lower methylated signal intensity 
(y axis) and a higher unmethylated signal intensity (x axis). 
From the density plots, a slight shift in distributions, which was 
most evident at the extremes of the beta-value range (i.e. 0 and 
1), could be seen for type 1 probes in both the green (Figure 2A) 
and red (Figure 2B) colour channels and type 2 probes 
(Figure 2C). This shift was most obvious for type 2 probes at 
the methylated end of the beta-value range, such that fewer 
sites in DBS samples showed the highest levels of DNA 
methylation. These differences in overall signal intensity were 
not, however, reflected by differences in the performance of 
the control probes. Plots of the output of these probes sup-
ported the conclusion that all arrays had performed well, with no 
obvious outliers (Figure 3). Importantly, the bisulphite conver-
sion control probes did not indicate a difference in bisulphite 
conversion efficiency between EDTA and DBS samples and 
the non-polymorphic control probes, which measure overall 
assay performance, did not appear to differ according to sample 
storage method.
In keeping with these observations, no samples were excluded 
based on the proportion of poorly detected sites. There was, 
however, a significant difference between the DBS and EDTA 
blood samples in the number of sites per sample with a poor 
detection p-value (p = 0.0177), such that the DBS samples had 
fewer sites per sample with a poor detection p-value than the EDTA 
samples (mean difference = -63.7 sites/sample). For the DBS 
samples, the total number of sites per sample with a poor detec-
tion p-value was not related to storage time (p = 0.498) or the 
amount of DNA hybridised to the array (p = 0.220).
In total, 292 sites were excluded as their beadcount was lower 
than three in at least five percent of samples and 2,280 sites 
were excluded due to having at least one percent of samples 
with a detection p-value greater than 0.05. Following the exclu-
sion of probes that have been predicted to cross-hybridise, 
452,278 probes were retained in the dataset, with this number 
being reduced to 436,309 after excluding probes on the X and 
Y chromosomes and those affected by a SNP at the CpG site or 
the site of single base extension (for type 1 probes).
Participant and sample characteristics
The mean age of the participants was 31.8 years (range = 18.1–
42.8 years; standard deviation = 7.2 years) and 62.9% of the 
Figure 1. Quality control plot showing median methylated and 
unmethylated raw signal intensities. For each sample, the log 
median methylated signal intensity (y-axis) is plotted against the log 
median unmethylated signal intensity (x-axis). Each dot represents 
one sample with EDTA samples being represented in green and 
DBS samples in orange.
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Figure 2. Density plots of the raw beta-values separated by probe type and methylation measurement unit. Density plots are shown 
for the type 1 (green colour channel (A); red colour channel (B)) and type 2 (C) probes. Each sample is represented by a separate line with 
EDTA samples indicated in green and dried blood spot (DBS) samples in orange.
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sample were female. Current smokers numbered 14, and 32 had 
never smoked. The mean storage time for the DBS samples was 
7.78 years (range = 5.79 – 9.96 years).
Assessment of the effect of storage method on whole 
blood cellular composition
Sample storage method (EDTA vs. DBS) was not observed to 
be associated with the proportion of any of the six estimated 
blood cell types (min. q = 0.103; Table 1).
Assessment of the comparability of DNA methylation 
profiles obtained from DBS and EDTA tube-stored whole 
blood samples
Using a subset of probes defined as showing variation in our 
sample (n = 190,044), Pearson correlation coefficients were 
calculated between all pairs of samples. For all participants, 
the highest correlation coefficient was observed between the 
two blood sample types (EDTA and DBS) from that participant 
(mean r = 0.991, range = 0.976 – 0.995). For comparison, the 
pairwise correlation coefficients between pairs of samples 
from different participants (across both storage methods) had 
a mean of r = 0.953 and ranged from 0.904 – 0.976. Consistent 
with these observations, unsupervised hierarchical clustering 
performed using the same variable set of probes indicated a 
high level of similarity between the DBS and EDTA samples 
from the same participant, with methylation differences being 
sufficient to distinguish between participants (Figure 4).
Assessment of the relationship between DNA methylation 
and Whatman FTA® card storage time
An EWAS was performed to establish whether the length 
of time that a sample is stored on a Whatman FTA® card is 
associated with altered DNA methylation. This did not reveal any 
significant differences (min. p = 1.19 × 10-5; summary statistics are 
available as Underlying data32)
Assessment of the effect of sample storage method on 
the relationship between DNA methylation and age and 
smoking
Age and smoking have been robustly associated with altered 
DNA methylation by several previous studies. EWASs were 
Figure 3. Control probe plots for the bisulphite conversion (I and II) and non-polymorphic probe control probes. The mean raw signal 
intensity for the bisulphite conversion (I and II) (A and B) and non-polymorphic (C) control probes are plotted for each array. EDTA samples 
are indicated in green and dried blood spot (DBS) samples in orange.
Table 1. Assessment of the relationship 
between blood cell type proportions and 
sample storage method. Six blood cell types 
were estimated using the estimateCellCounts 
function in the R package minfi and associations 
with method of blood sample storage (EDTA tube 
vs. Whatman FTA card) were assessed by paired 
t-tests. A Benjamini-Hochberg false discovery rate 
(FDR) adjustment (q-value) was applied to account 
for the number of tests carried out and statistical 
significance was defined as q ≤ 0.05.
Cell type t-statistic p-value q-value
B-cells -0.63 0.528 0.736
CD4+ T-cells -1.56 0.124 0.373
CD8+ T-cells 2.45 0.0171 0.103
Granulocytes 0.34 0.736 0.736
Monocytes 0.40 0.687 0.736
Natural Killer cells -1.19 0.240 0.480
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Figure 4. Unsupervised hierarchical clustering of methylation levels (beta-values) at variable probes. A subset of 190,044 probes 
defined as variable using an approach described by Hannon et al. (2015)27 were used to perform unsupervised hierarchical clustering of the 
124 samples. Each sample is labelled using the participants study identifier and a suffix indicating whether the sample was from DNA from 
whole blood stored as a dried blood spot (DBS) or in an EDTA tube.
carried out to (i) identify age- and smoking-associated differ-
entially methylated positions (DMPs) in the EDTA and DBS 
samples when considered separately and (ii) assess whether 
sample storage method exerted an effect on these associa-
tions. EWASs for age and smoking status identified significant 
DMPs in both the EDTA and the DBS samples (Table 2–Table 5; 
complete summary statistics are available as Underlying data32), 
while no significant associations were identified between DNA 
methylation and the interaction between storage method and age 
or smoking (min p = 5.57 × 10-6; summary statistics are available 
as Underlying data32).
Discussion
In agreement with previous studies, we have demonstrated that 
it is possible to obtain high quality DNA methylation profiles 
from archived DBSs stored on Whatman FTA® cards and, for 
the first time, shown that these profiles are highly compara-
ble to those obtained from matched whole blood DNA obtained 
from samples stored in EDTA tubes. Our findings support the 
use of Whatman FTA® cards for the routine collection of blood 
samples for studies of DNA methylation. There are potentially 
substantial benefits to this approach, particularly for large-scale 
studies and those carried out in rural or remote settings and/or 
in low- and middle-income countries. The blood collection 
by finger prick protocol is comparable to that used for blood 
glucose monitoring in diabetes and could be self-administered 
by study participants.
DNA methylation profiles obtained from the DBSs appeared 
to be of good quality: on almost all comparison metrics, the 
performance of the DBS samples could not be distinguished 
from the performance of the EDTA tube samples. There was a 
tendency for DBS samples to have higher methylated signal 
intensity and lower unmethylated signal intensity than the EDTA 
samples, but this did not result in a difference in the perform-
ance of the control probes, or in the number of sites with a poor 
detection p-value. Encouragingly, the overall rate of site detec-
tion was slightly better in the DBS samples than the EDTA 
samples. These observations support and extend those of pre-
vious studies in which DBS DNA (both from Whatman FTA® 
cards and other card types) has been profiled successfully using 
Infinium BeadArrays12,33–37.
Two concerns cited when considering the use of archived DBSs 
are the effects of sample quantity and degradation with storage 
time14. Here we demonstrate that despite obtaining less DNA 
than recommended as input for the Infinium HumanMeth-
ylation450 BeadChip from 19 of the DBS samples, high 
quality methylation profiles were obtained. Moreover, we did not 
observe an effect of storage time on the success of methylation 
profiling; however, as the longest time that a sample was stored 
on a Whatman FTA® card in the present study was 10 years, it 
remains possible that longer storage times might exert an effect. 
An earlier demonstration of successful methylation profiling 
of two DBS samples that had been stored for 26–28 years on 
standard filter paper35 does, however, provide additional support 
for the notion that extended storage time (as is the case for 
some potentially valuable archival sample collections) might not 
exert a deleterious effect.
Correlation and unsupervised hierarchical clustering analyses 
demonstrated a high degree of concordance between the DNA 
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Table 4. The top 10 significant results from an epigenome-wide association study (EWAS) of age carried 
out using dried blood spot (DBS) samples. For the first 10 loci, the CpG name, the symbol and name of the 
gene that the CpG is located in (or NA if the CpG is not located in a gene), genomic coordinate of the CpG 
(GRCh37), t-statistic and p-value are shown. Results are ranked by p-value.
CpG Name Gene Symbol Gene Name Chr. Position t p-value
cg16867657 ELOVL2 ELOVL fatty acid elongase 2 6 11044877 16.04 1.85 × 10-18
cg10501210 NA NA 1 207997020 -9.39 2.01 × 10-11
cg07553761 TRIM59 tripartite motif containing 59 3 160167977 9.36 2.20 × 10-11
cg24724428 ELOVL2 ELOVL fatty acid elongase 2 6 11044888 8.97 6.65 × 10-11
cg06639320 FHL2 four and a half LIM domains 2 2 106015739 8.75 1.26 × 10-10
cg22454769 FHL2 four and a half LIM domains 2 2 106015767 8.58 2.07 × 10-10
cg23606718 AMER3 APC membrane recruitment protein 3 2 131513927 7.71 2.86 × 10-9
cg21572722 ELOVL2 ELOVL fatty acid elongase 2 6 11044894 7.41 7.11 × 10-9
cg12934382 GRM2 glutamate metabotropic receptor 2 3 51741135 7.27 1.09 × 10-8
cg08957484 CCNI2 cyclin I family member 2 5 132083532 7.20 1.36 × 10-8
Table 2. Significant results from an epigenome-wide association study (EWAS) comparing current 
and never smokers carried out using dried blood spot (DBS) samples. For loci attaining a genome-
wide significant p-value (≤3.6 × 10-8), the CpG name, the symbol and name of the gene that the CpG is 
located in (or NA if the CpG is not located in a gene), genomic coordinate of the CpG (GRCh37), t-statistic 
and p-value are shown. Results are ranked by p-value.
CpG Name Gene Symbol Gene Name Chr. Position t p-value
cg05575921 AHRR aryl-hydrocarbon receptor repressor 5 373378 -11.18 1.06 × 10-13
cg26703534 AHRR aryl-hydrocarbon receptor repressor 5 377358 -8.35 3.35 × 10-10
cg21161138 AHRR aryl-hydrocarbon receptor repressor 5 399360 -7.05 1.88 × 10-8
Table 3. Significant results from an epigenome-wide association study (EWAS) comparing current 
and never smokers carried out using EDTA samples. For loci attaining a genome-wide significant  
p-value (≤3.6 × 10-8), the CpG name, the symbol and name of the gene that the CpG is located in (or NA 
if the CpG is not located in a gene), genomic coordinate of the CpG (GRCh37), t-statistic and p-value are 
shown. Results are ranked by p-value.
CpG Name Gene Symbol Gene Name Chr. Position t p-value
cg05575921 AHRR aryl-hydrocarbon receptor repressor 5 373378 -10.09 2.12 × 10-12
cg26703534 AHRR aryl-hydrocarbon receptor repressor 5 377358 -7.54 4.00 × 10-9
cg21161138 AHRR aryl-hydrocarbon receptor repressor 5 399360 -7.41 6.11 × 10-9
methylation profiles obtained from the Whatman FTA® DBSs 
and the EDTA samples. These findings are consistent with those 
of Joo et al. (2013)36 and Hollegard et al. (2013)35 who showed 
methylation profiles obtained from DBS DNA samples to 
be highly correlated and/or cluster with those from paired buffy 
coat DNA or whole blood DNA samples from the same individ-
ual. These studies only considered small numbers of participants 
(n = two or five) for whom the DBSs had been stored for three 
years, rendering our findings in 62 participants with DBSs that 
had been stored for a mean period of eight years an important 
addition to previous studies.
EWASs of smoking and age in both the DBS and EDTA sam-
ples produced results that replicated previously established 
associations identified using peripheral blood DNA. The most 
significant locus identified in the EWASs of smoking status 
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in both sample types was cg05575921 in AHRR, which was 
hypomethylated in smokers. This replicates multiple previous 
studies38,39, including meta-analyses40,41, and cg05575921 has 
been suggested as a biomarker of smoking status42. Interestingly, 
one of the validation cohorts (Melbourne Collaborative Cohort 
Study43) assessed by Fasanelli et al. (2015)39 comprised 75% 
DBS samples. This cohort was used to successfully validate the 
two most significant DMPs (including cg05575921) identified in 
the discovery cohort.
The most significant locus in the EWASs of age in both the 
DBS and EDTA samples was cg16867657 in ELOVL2, where 
methylation was positively correlated with age, replicating 
previous studies44,45. Methylation at this locus has been sug-
gested as a biomarker of aging, with potential utility for forensic 
investigation46. 
No significant associations were observed between DNA 
methylation and the interaction between smoking or age and 
storage method. This observation indicates that storing blood 
samples as DBSs at room temperature for approximately eight 
years is unlikely to affect the results of EWASs for traits that are 
robustly associated with variation in DNA methylation.
It is of interest to consider these findings in the context Dugué 
et al.’s (2016)47 demonstration of lower reliability of DNA meth-
ylation profiling of DBSs using Infinium HumanMethylation450 
BeadChips (compared to the moderate reliability of periph-
eral blood mononuclear cell DNA samples). This finding, which 
was based on the calculation of probe-wise intraclass correla-
tion coefficients for technical replicates (ICC; the median of 
which was 0.20 for DBS technical replicates), suggests that, in 
general, there is a higher degree of measurement error when 
assaying DBS DNA. In light of this finding, Dugué et al. 
suggested that it may be advisable to only include probes 
with an ICC above a certain threshold when carrying out 
EWASs using DBS samples. It is clear from the present 
results, however, that measurement error was not so large as to 
obfuscate the pair-wise relationship between samples in the 
study or to confound EWASs of variables known to be robustly 
associated with variation in DNA methylation.
A disadvantage to storing blood samples using Whatman FTA® 
cards is that it is not possible to sort the sample into separate blood 
cell types. As DNA methylation varies between blood cell types, 
the issue of cellular heterogeneity must be addressed in order 
to avoid confounding in EWASs using whole blood DNA25,26. 
Fortunately, several algorithms have been developed previously 
to deal with the issue of cellular heterogeneity in EWAS studies 
(see Kaushal et al., 201748 for a comparison of these methods) 
and our data supports the applicability of these to blood samples 
stored using Whatman FTA® cards.
Taken together, the results of this study support the use of 
Whatman FTA® cards as an alternative, more cost- and space- 
effective storage method for blood samples collected for DNA 
methylation studies. We demonstrate that DNA from DBSs stored 
for up to 10 years can be successfully profiled using Infinium 
BeadChips, producing methylation profiles that are highly 
correlated with matched EDTA samples. We envisage that this 
approach to collecting and storing blood samples for DNA 
methylation profiling will help circumvent many issues faced 
by researchers amassing large collections of blood samples, 
particularly where access to freezer facilities is limited. These 
findings are also relevant to the ongoing discussion regarding the 
potential use of new-born Guthrie cards for research purposes 
and supports previous work assessing the potential for methylomic 
profiling of these samples34–36,49,50.
Data availability
Underlying data
Due to the confidential and potentially identifiable nature of 
the DNA methylation data and participant phenotypic infor-
mation, it is not possible to publically share the individual level 
Table 5. The top 10 significant results from an epigenome-wide association study (EWAS) of age carried 
out using EDTA samples. For the first 10 loci, the CpG name, the symbol and name of the gene that the CpG 
is located in (or NA if the CpG is not located in a gene), genomic coordinate of the CpG (GRCh37), t-statistic 
and p-value are shown. Results are ranked by p-value.
CpG Name Gene Symbol Gene Name Chr. Position t p-value
cg16867657 ELOVL2 ELOVL fatty acid elongase 2 6 11044877 11.61 4.88 × 10-14
cg22454769 FHL2 four and a half LIM domains 2 2 106015767 7.94 1.41 × 10-9
cg10501210 NA NA 1 207997020 -7.91 1.53 × 10-9
cg07547549 SLC12A5 solute carrier family 12 member 5 20 44658225 7.48 5.71 × 10-9
cg16419235 PENK proenkephalin 8 57360613 7.34 8.83 × 10-9
cg06639320 FHL2 four and a half LIM domains 2 2 106015739 7.29 1.01 × 10-8
cg21572722 ELOVL2 ELOVL fatty acid elongase 2 6 11044894 6.68 6.78 × 10-8
cg23606718 AMER3 APC membrane recruitment protein 3 2 131513927 6.60 8.74 × 10-8
cg17737621 NA NA 20 21372480 6.60 8.80 × 10-8
cg23500537 NA NA 5 140419819 6.57 9.58 × 10-8
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data used for these analyses. Researchers can, however, request 
access to all GS data by contacting the GS Access Committee 
(access@generationscotland.org). GS operates a managed data 
access process including an online application form, which 
will be reviewed by the GS Access Committee. Summary infor-
mation to help researchers assess the feasibility and statisti-
cal power of a proposed project can be requested by contacting 
resources@generationscotland.org. Epigenome-wide association 
study (EWAS) summary statistics are available from the University 
of Edinburgh DataShare website.
Edinburgh DataShare: Comparison of DNA methylation profiles 
from Generation Scotland blood samples stored on Whatman 
FTA cards and in EDTA tubes: EWAS summary statistics. https://
doi.org/10.7488/ds/250232
This project contains the following underlying data:
•    storage_time_DBS_EWAS_summary_stats.csv (EWAS of 
storage time carried out using blood samples stored on 
Whatman FTA cards)
•    age_EDTA_EWAS_summary_stats.csv (EWAS of age 
carried out using blood samples stored in EDTA tubes)
•    age_DBS_EWAS_summary_stats.csv (EWAS of age 
carried out using blood samples stored on Whatman FTA 
cards)
•    smoking_EDTA_EWAS_summary_stats.csv (EWAS of 
current vs. never smokers carried out using blood samples 
stored in EDTA tubes)
•    smoking_DBS_EWAS_summary_stats.csv (EWAS of cur-
rent vs. never smokers carried out using blood samples stored 
on Whatman FTA cards)
•    age_storage_method_interaction_EWAS_summary_stats.csv 
(EWAS of the interaction between age and storage method 
(EDTA tube vs. Whatman FTA card) carried out using 
paired blood samples)
•    smoking_storage_method_interaction_EWAS_summary_ 
stats.csv (EWAS of the interaction between smoking 
status (current or never) and storage method (EDTA tube 
vs. Whatman FTA card) carried out using paired blood 
samples)
Data are available under the terms of the Creative Commons 
Attribution 4.0 International license (CC-BY 4.0).
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